Yazdan Yazdanpanah to Hepatitis C, Chronic
This is a "connection" page, showing publications Yazdan Yazdanpanah has written about Hepatitis C, Chronic.
Connection Strength
0.913
-
Assessing the cost-effectiveness of hepatitis C screening strategies in France. J Hepatol. 2018 Oct; 69(4):785-792.
Score: 0.371
-
Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France. J Viral Hepat. 2018 10; 25(10):1197-1207.
Score: 0.367
-
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study). HIV Med. 2018 03; 19(3):227-237.
Score: 0.089
-
Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study. J Hepatol. 2017 09; 67(3):454-461.
Score: 0.085